Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2016 (2016), Article ID 2787623, 6 pages
http://dx.doi.org/10.1155/2016/2787623
Research Article

In Vitro Evaluation of the Antimicrobial Ability and Cytotoxicity on Two Melanoma Cell Lines of a Benzylamide Derivative of Maslinic Acid

1Department of Pharmacognosy, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timişoara, Romania
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timişoara, Romania
3Department of Toxicology, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timişoara, Romania
4Department of Microbiology and Virology, Faculty of Medicine, “Victor Babeş” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timişoara, Romania
5Department of Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes Str. 2, D-06120 Halle (Saale), Germany
6Department of Pathophysiology, Faculty of Medicine, “Victor Babeş” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timişoara, Romania
7Center for Translational Research and Systems Medicine, “Victor Babeş” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timişoara, Romania

Received 2 August 2016; Revised 19 October 2016; Accepted 13 November 2016

Academic Editor: Consuelo Amantini

Copyright © 2016 Ioana Zinuca Pavel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lozano-Mena, M. Sánchez-González, M. E. Juan, and J. M. Planas, “Maslinic acid, a natural phytoalexin-type triterpene from olives—a promising nutraceutical?” Molecules, vol. 19, no. 8, pp. 11538–11559, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Hashmi, A. Khan, M. Hanif, U. Farooq, and S. Perveen, “Traditional uses, phytochemistry, and pharmacology of Olea europaea (Olive),” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 541591, 29 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Jäger, H. Trojan, T. Kopp, M. N. Laszczyk, and A. Scheffler, “Pentacyclic triterpene distribution in various plants—rich sources for a new group of multi-potent plant extracts,” Molecules, vol. 14, no. 6, pp. 2016–2031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Sánchez-Quesada, A. López-Biedma, F. Warleta, M. Campos, G. Beltrán, and J. J. Gaforio, “Bioactive properties of the main triterpenes found in olives, virgin olive oil, and leaves of olea europaea,” Journal of Agricultural and Food Chemistry, vol. 61, no. 50, pp. 12173–12182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Siewert, E. Pianowski, A. Obernauer, and R. Csuk, “Towards cytotoxic and selective derivatives of maslinic acid,” Bioorganic and Medicinal Chemistry, vol. 22, no. 1, pp. 594–615, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Parra, F. Rivas, S. Martin-Fonseca, A. Garcia-Granados, and A. Martinez, “Maslinic acid derivatives induce significant apoptosis in b16f10 murine melanoma cells,” European Journal of Medicinal Chemistry, vol. 46, no. 12, pp. 5991–6001, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Bosserhoff and L. Strizzi, “Introduction,” in Melanoma Development—Molecular Biology, Genetics and Clinical Application, A. Bosserhoff, Ed., pp. 1–7, Springer, New York, NY, USA, 2011. View at Google Scholar
  8. M. F. Naylor, “Practical management of melanoma,” in Skin Cancer Management—A Practical Approach, D. F. MacFarlane, Ed., pp. 203–217, Springer, Houston, Tex, USA, 2010. View at Google Scholar
  9. L. Yang, X. Ma, L. Xiao et al., “Uniquely modified RNA oligonucleotides targeting STAT3 suppress melanoma growth both in vitro and in vivo,” Cancer Biology and Therapy, vol. 8, no. 21, pp. 2065–2072, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Kamarashev, L. Schärer, M. C. Zipser, L. L. Lockwood, and R. Dummer, “Disease entities: malignant melanoma,” in Skin Cancer-a World-wide Perspective, R. Dummer, M. R. Pittelkow, K. Iwatsuki, A. Green, and N. M. Elwan, Eds., pp. 169–186, Springer, Berlin, Germany, 2011. View at Google Scholar
  11. P. Courvalin, “Predictable and unpredictable evolution of antibiotic resistance,” Journal of Internal Medicine, vol. 264, no. 1, pp. 4–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Chouaïb, F. Hichri, A. Nguir et al., “Semi-synthesis of new antimicrobial esters from the natural oleanolic and maslinic acids,” Food Chemistry, vol. 183, pp. 8–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Zheng, Y.-K. Lee, Y. Li et al., “Inhibition of DNA topoisomerases i and II and cytotoxicity of compounds from Ulmus davidiana var. japonica,” Archives of Pharmacal Research, vol. 33, no. 9, pp. 1307–1315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Goswami and H. N. Khastgir, “Partial synthesis of 2α,3β-diacetoxy-28-nor-oleana-12,17-diene, a degradation product of baccatin,” Indian Journal of Chemistry-Section B, vol. 19, pp. 315–316, 1980. View at Google Scholar
  15. B. Singh, V. P. Singh, V. B. Pandey, and G. Rucker, “A new triterpene glycoside from Terminalia arjuna,” Planta Medica, vol. 61, no. 6, pp. 576–577, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. R. Anjaneyulu, A. V. R. Reddy, G. R. Mallavarapu, and R. S. Chandrasekhara, “3-acetylmaslinic acid from the root bark of Terminalia alata,” Phytochemistry, vol. 25, no. 11, pp. 2670–2671, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. Reyes-Zurita, E. E. Rufino-Palomares, J. A. Lupiáñez, and M. Cascante, “Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway,” Cancer Letters, vol. 273, no. 1, pp. 44–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. J. Reyes-Zurita, E. E. Rufino-Palomares, P. P. Medina et al., “Antitumour activity on extrinsic apoptotic targets of the triterpenoid maslinic acid in p53-deficient Caco-2 adenocarcinoma cells,” Biochimie, vol. 95, no. 11, pp. 2157–2167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Li, Z. Yang, C. Zhai et al., “Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway,” Molecular Cancer, vol. 9, article 73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D.-M. Wu, D. Zhao, D.-Z. Li, D.-Y. Xu, W.-F. Chu, and X.-F. Wang, “Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 383, no. 3, pp. 321–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. V. H. Villar, O. Vögler, F. Barceló et al., “Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein,” Journal of Nutritional Biochemistry, vol. 25, no. 4, pp. 429–438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. X. He and R. H. Liu, “Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity,” Journal of Agricultural and Food Chemistry, vol. 55, no. 11, pp. 4366–4370, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Allouche, F. Warleta, M. Campos et al., “Antioxidant, antiproliferative, and pro-apoptotic capacities of pentacyclic triterpenes found in the skin of olives on MCF-7 human breast cancer cells and their effects on DNA damage,” Journal of Agricultural and Food Chemistry, vol. 59, no. 1, pp. 121–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-K. Kim, S. K. Yoon, and S. Y. Ryu, “Cytotoxic triterpenes from stem bark of Physocarpus intermedius,” Planta Medica, vol. 66, no. 5, pp. 485–486, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Jesus, J. H. G. Lago, M. D. Laurenti, E. S. Yamamoto, and L. F. D. Passero, “Antimicrobial activity of oleanolic and ursolic acids: an update,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 620472, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Kreander, P. Vuorela, and P. Tammela, “A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of finnish origin,” Folia Microbiologica, vol. 50, no. 6, pp. 487–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Courvalin, “Why is antibiotic resistance a deadly emerging disease?” Clinical Microbiology and Infection, vol. 22, no. 5, pp. 405–407, 2016. View at Publisher · View at Google Scholar
  28. H. J. Morrill, J. M. Pogue, K. S. Kaye, and K. L. LaPlante, “Treatment options for carbapenem-resistant enterobacteriaceae infections,” Open Forum Infectious Diseases, vol. 2, no. 2, 2015. View at Publisher · View at Google Scholar
  29. J.-C. He, M.-M. Han, K.-Y. Li, and P. Dong, “Streptomycin ototoxicity in rat cochlear organotypic cultures,” Cell Biochemistry and Biophysics, vol. 71, no. 2, pp. 851–856, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. B. J. McMullan and M. Mostaghim, “Prescribing azithromycin,” Australian Prescriber, vol. 38, no. 3, pp. 87–90, 2015. View at Publisher · View at Google Scholar · View at Scopus